P113-0687 Screening compound: 8-[2-(4-phenylpiperazin-1-yl)-1,3-thiazole-4-carbonyl]-1,4-dioxa-8-azaspiro[4.5]decane

P113-0687 Screening compound: 8-[2-(4-phenylpiperazin-1-yl)-1,3-thiazole-4-carbonyl]-1,4-dioxa-8-azaspiro[4.5]decane
P113-0687 Screening compound: 8-[2-(4-phenylpiperazin-1-yl)-1,3-thiazole-4-carbonyl]-1,4-dioxa-8-azaspiro[4.5]decane alternative view

Chemical Structure Depiction of ChemDiv screening compound P113-0687
8-[2-(4-phenylpiperazin-1-yl)-1,3-thiazole-4-carbonyl]-1,4-dioxa-8-azaspiro[4.5]decane

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P113-0687

Molecular Formula

C21H26N4O3S (C21 H26 N4 O3 S)

Compound Name

8-[2-(4-phenylpiperazin-1-yl)-1,3-thiazole-4-carbonyl]-1,4-dioxa-8-azaspiro[4.5]decane

IUPAC name

8-[2-(4-phenylpiperazin-1-yl)-13-thiazole-4-carbonyl]-14-dioxa-8-azaspiro[4.5]decane

SMILES

O=C(c1csc(N(CC2)CCN2c2ccccc2)n1)N(CC1)CCC11OCCO1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

414.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.785

Distribution Coefficient, logD

2.785

Water Solubility, LogSw

-3.05

Polar Surface Area

47.857

Acid Dissociation Constant (pKa)

23.18

Base Dissociation Constant (pKb)

2.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.40

P113-0687 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with P113-0687 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P113-0687?
Check Price and Availability of P113-0687, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P113-0687 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P113-0687
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P113-0687
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P113-0687 available by request